OBI-902 has been granted by US FDA for Orphan Drug Designation for the treatment of...

Sino Biopharmaceutical announces LM-350 a CDH17 ADC has received the IND approval from NMPA

Radiopharm Theranostics receives IND approval to initiate Phase 1 therapeutic trial of RAD 402 (KLK3-mAb...

TriOar signs $356 million technology transfer agreement with Celltrion

Daan Biotherapeutics and TriOar sign MOU for strategic collaboration on next-generation antibody-drug conjugate development

GlycoNex announced a collaborative research agreement with Hokkaido University Hospital to support the development of...